Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection

NCT07450612 is registered in ClinicalTrials.gov with San Raffaele University as lead sponsor.

NCT NCT07450612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07450612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
Lead sponsor
San Raffaele University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2024
Completion date
August 15, 2031
Enrollment
1,200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adenoma colon, adenoma colon polyp, colo-rectal cancer, colon adenoma, colon disease, colon neoplasm, colorectal cancer, epcam gene mutation, lyn gene mutation, lynch syndrome, lynch syndrome i, lynch syndrome i (site-specific colonic cancer), lynch syndrome ii, mismatch repair deficiency, mismatch repair gene mutation, mlh1 gene mutation, msh2 gene mutation, msh6 gene mutation, pms2 gene mutation